Peter Neumann joined Melanie Whittington, Managing Director and Head of the Leerink Center for Pharmacoeconomics and CEVR Senior Fellow, to discuss cost-effectiveness analysis, Medicare drug price negotiations, international reference pricing, and the policy tradeoffs between affordability, access, and incentives for innovation.
Listen here.
